Following People With Eczema and Related Allergic Diseases Over Time
Observes people with atopic dermatitis and asthma, collecting clinical and laboratory data over time.
Plain-language title generated from the registry record
Registry title: Prospective Longitudinal Observational Research in Atopic Dermatitis
Key facts
- Where
- Zurich, SwitzerlandSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 1 and 85 years old?
Source: NCT04240522, who can take part
Where in Switzerland
- Allergy Unit, Dept. of Dermatology, Unviersity Hosptial of ZurichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Zurich
- Trial code
- NCT04240522
- Record updated
- 5 February 2026
- Original description
Atopic dermatitis (AD) is a frequent chronic relapsing inflammatory skin disorder, characterized by intensely itchy eczema. AD usually starts within the first 2 years of life. In 30 - 60% of children, inflammation spreads onto other body surfaces such as the gastrointestinal tract, the respiratory tract, and the conjunctives within a few years. This sequence is called atopic march.Read full original descriptionShow less
Prospective Longitudinal Observational Research Study to Investigate the Remission of Atopic Dermatitis and Associated Allergic Diseases
Atopic dermatitis (AD) is a frequent chronic relapsing inflammatory skin disorder, characterized by intensely itchy eczema. AD usually starts within the first 2 years of life. In 30 - 60% of children, inflammation spreads onto other body surfaces such as the gastrointestinal tract, the respiratory tract, and the conjunctives within a few years. This sequence is called atopic march.
Atopic dermatitis and associated atopic diseases are more frequent in families, suggesting a genetic predisposition. However, the underlying factors such as genetic phenotype, environmental factors, or life style which cause or worsen an existing allergic disease are not understood yet. Affected people suffer from recurrent flares that result in significantly impaired quality.
This study will collect clinical and laboratory data to elucidate immunotolerance and preventiv stategies with the aim to develop new and individual treatment options of atopic diseases.
Inclusion: Age 0 - 85 years; Diagnosis of AD and/or another disease of the atopic group (i.e. allergic rhinitis, allergic asthma, food allergy); The inclusion of patients in this study is independent from the current therapy. During the study all patients will be kept on a therapy that is medically indicated; The inclusion criteria for healthy controls in this study are as follows:; Age 0 - 85 years; No diagnosis or history of allergic disease; The inclusion of patients in this study is independent from the current therapy. During the study all patients will be kept on a therapy that is medically indicated; Written consent will be obtained after detailed information of the study was given to the participant.
Exclusion: Unable to give consent or refusal to participate in the study.